These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2283041)

  • 21. Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.
    Miyamoto O; Minami J; Toyoshima T; Nakamura T; Masada T; Nagao S; Negi T; Itano T; Okabe A
    Infect Immun; 1998 Jun; 66(6):2501-8. PubMed ID: 9596708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of p-chloromercuribenzoate on Clostridium perfringens beta toxin.
    Sakurai J; Fujii Y; Nagahama M
    Toxicon; 1992 Mar; 30(3):323-30. PubMed ID: 1529464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Clostridium perfringens epsilon toxin on MDCK cells.
    Borrmann E; Günther H; Köhler H
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):85-92. PubMed ID: 11549414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
    Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
    Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of labeled Clostridium perfringens epsilon toxin in mice.
    Nagahama M; Sakurai J
    Toxicon; 1991; 29(2):211-7. PubMed ID: 2048139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of epsilon-toxin from Clostridium perfringens in the nervous system.
    Dorca-Arévalo J; Soler-Jover A; Gibert M; Popoff MR; Martín-Satué M; Blasi J
    Vet Microbiol; 2008 Sep; 131(1-2):14-25. PubMed ID: 18406080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of endothelial barrier antigen immunoreactivity as a marker of Clostridium perfringens type D epsilon toxin-induced microvascular damage in rat brain.
    Finnie JW; Manavis J; Chidlow G
    J Comp Pathol; 2014; 151(2-3):153-6. PubMed ID: 24973988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological and pharmacological properties of Clostridium perfringens alpha toxin].
    Fujii Y
    Nihon Saikingaku Zasshi; 1991 Sep; 46(5):817-26. PubMed ID: 1762173
    [No Abstract]   [Full Text] [Related]  

  • 30. Clostridium perfringens epsilon toxin inhibits the gastrointestinal transit in mice.
    Losada-Eaton DM; Fernandez-Miyakawa ME
    Res Vet Sci; 2010 Dec; 89(3):404-8. PubMed ID: 20434186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus.
    Miyamoto O; Sumitani K; Nakamura T; Yamagami S; Miyata S; Itano T; Negi T; Okabe A
    FEMS Microbiol Lett; 2000 Aug; 189(1):109-13. PubMed ID: 10913875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.
    Hughes ML; Poon R; Adams V; Sayeed S; Saputo J; Uzal FA; McClane BA; Rood JI
    J Bacteriol; 2007 Nov; 189(21):7531-8. PubMed ID: 17720791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.
    Stevens DL; Troyer BE; Merrick DT; Mitten JE; Olson RD
    J Infect Dis; 1988 Feb; 157(2):272-9. PubMed ID: 2891775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance.
    Tamai E; Ishida T; Miyata S; Matsushita O; Suda H; Kobayashi S; Sonobe H; Okabe A
    Infect Immun; 2003 Sep; 71(9):5371-5. PubMed ID: 12933886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of the carboxy-terminal region of Clostridium perfringens alpha toxin.
    Nagahama M; Iida H; Nishioka E; Okamoto K; Sakurai J
    FEMS Microbiol Lett; 1994 Jul; 120(3):297-301. PubMed ID: 8076805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Molecular Architecture and Mode of Action of
    Titball RW
    Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668605
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of drugs acting on the central nervous system on the lethality in mice of Clostridium perfringens epsilon toxin.
    Nagahama M; Sakurai J
    Toxicon; 1993 Apr; 31(4):427-35. PubMed ID: 8099239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells.
    Shortt SJ; Titball RW; Lindsay CD
    Hum Exp Toxicol; 2000 Feb; 19(2):108-16. PubMed ID: 10773840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model.
    Fernandez-Miyakawa ME; Fisher DJ; Poon R; Sayeed S; Adams V; Rood JI; McClane BA; Uzal FA
    Infect Immun; 2007 Mar; 75(3):1443-52. PubMed ID: 17210666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.